These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7846755)

  • 1. Acute digoxin overdose in a newborn with renal failure: use of digoxin immune Fab and peritoneal dialysis.
    Berkovitch M; Akilesh MR; Gerace R; Verjee Z; McGuigan M; Whyte H; Koren G
    Ther Drug Monit; 1994 Oct; 16(5):531-3. PubMed ID: 7846755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin intoxication in a patient with end-stage renal disease: efficacy of digoxin-specific Fab antibody fragments and peritoneal dialysis.
    Caspi O; Zylber-Katz E; Gotsman O; Wolf DG; Caraco Y
    Ther Drug Monit; 1997 Oct; 19(5):510-5. PubMed ID: 9357092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of digoxin intoxication in a renal failure patient with digoxin-specific antibody fragments and plasmapheresis.
    Rabetoy GM; Price CA; Findlay JW; Sailstad JM
    Am J Nephrol; 1990; 10(6):518-21. PubMed ID: 2075910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digitalis intoxication and treatment with digoxin antibody fragments in renal failure.
    Erdmann E; Mair W; Knedel M; Schaumann W
    Klin Wochenschr; 1989 Jan; 67(1):16-9. PubMed ID: 2921838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance.
    Zdunek M; Mitra A; Mokrzycki MH
    Am J Kidney Dis; 2000 Jul; 36(1):177-83. PubMed ID: 10873888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin poisoning and anuric acute renal failure: efficiency of the treatment associating digoxin-specific antibodies (Fab) and plasma exchanges.
    Chillet P; Korach JM; Petitpas D; Vincent N; Poiron L; Barbier B; Boazis M; Berger PH
    Int J Artif Organs; 2002 Jun; 25(6):538-41. PubMed ID: 12117293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.
    Ujhelyi MR; Robert S
    Clin Pharmacokinet; 1995 Jun; 28(6):483-93. PubMed ID: 7656506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD; Wenger T; Smith TW; Lovejoy FH
    N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute massive digoxin overdose: survival without use of digitalis-specific antibodies.
    Springer M; Olson KR; Feaster W
    Am J Emerg Med; 1986 Jul; 4(4):364-8. PubMed ID: 3718631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments].
    Milani L; Bizzaro N; Sanson A
    G Ital Cardiol; 1992 Jan; 22(1):97-101. PubMed ID: 1624074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
    Chan BS; Isbister GK; O'Leary M; Chiew A; Buckley NA
    Clin Toxicol (Phila); 2016 Jul; 54(6):488-94. PubMed ID: 27118413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.
    Antman EM; Wenger TL; Butler VP; Haber E; Smith TW
    Circulation; 1990 Jun; 81(6):1744-52. PubMed ID: 2188752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of CAVH to remove digoxin-Fab complex in piglets.
    Quaife EJ; Banner W; Vernon DD; Christensen DW
    J Toxicol Clin Toxicol; 1990; 28(1):61-8. PubMed ID: 2381023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of clinical experience with digoxin immune Fab (ovine).
    Smith TW
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):1-6; discussion 33-4. PubMed ID: 1997014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent digoxin overdose and treatment with digoxin-specific Fab antibody fragments.
    Bosse GM; Pope TM
    J Emerg Med; 1994; 12(2):179-85. PubMed ID: 8207153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pharmacokinetic profiles of digoxin immune Fab in four patients with renal impairment.
    Allen NM; Dunham GD; Sailstad JM; Findlay JW
    DICP; 1991 Dec; 25(12):1315-20. PubMed ID: 1815424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculated decisions: DigiFab® (Digibind®) Dosing for Digoxin Poisoning.
    Lucyk S
    Emerg Med Pract; 2020 Sep; 22(Suppl 9):CD1-CD3. PubMed ID: 33476509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-specific Fab and therapeutic plasma exchange for digitalis intoxication and renal failure.
    Pellegrino M; Garofalo M
    Am J Emerg Med; 2019 Apr; 37(4):798.e3-798.e5. PubMed ID: 30770242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and efficacy of digoxin specific Fab fragments in a child following massive digoxin overdose.
    Kearns GL; Moss MM; Clayton BD; Hewett DD
    J Clin Pharmacol; 1989 Oct; 29(10):901-8. PubMed ID: 2592582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxin.
    Ujhelyi MR; Robert S; Cummings DM; Colucci RD; Green PJ; Sailstad J; Vlasses PH; Zarowitz BJ
    Ann Intern Med; 1993 Aug; 119(4):273-7. PubMed ID: 8328735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.